|
|
||||||||
CURE: Digestive Diseases Research Center, West Los Angeles Veterans Affairs Medical Center, and Digestive Diseases Division, Department of Medicine and Brain Research Institute, University of California, Los Angeles, California 90073
Thyrotropin-releasing hormone (TRH) acts in
brain stem nuclei to induce vagally mediated stimulation of gastric
secretion. The effects of intracisternal injection of the TRH analog
RX-77368 on plasma gastrin levels and corpus histidine decarboxylase
(HDC) activity were studied in 48-h fasted conscious rats. RX-77368 (25-100 ng) increased plasma gastrin levels by threefold at 30 min, which remained significantly higher than control at 2 and 4 h
postinjection. Corpus HDC activity began to increase at 2 h and reached a peak at 4 h postinjection with a 21-fold maximum response observed at 50 ng. Morphological changes in the appearance of
corpus HDC-immunoreactive cells correlated well with HDC activity. Pretreatment with gastrin monoclonal antibody completely prevented RX-77368 stimulatory effects on HDC activity. Atropine significantly attenuated gastrin increase at 30 min by 26%. These results indicated that in conscious fasted rats, TRH analog acts in the brain to increase
corpus HDC activity in the enterochromaffin-like cells, which involves
gastrin release stimulated by central TRH analog.
enterochromaffin-like cell; gastrin monoclonal antibody; vagus; thyrotropin-releasing hormone
This article has been cited by other articles:
![]() |
A. K. Sandvik, G. Cui, I. Bakke, B. Munkvold, and H. L. Waldum PACAP stimulates gastric acid secretion in the rat by inducing histamine release Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G997 - G1003. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |